DIAGNOSING ALZHEIMER'S DISEASE IN THE BLINK OF AN EYE
A Simple Eye Scan to Detect a Key Biomarker of Alzheimer's Disease
Optina Diagnostics is developing an innovative tool that will transform AD research by enabling the identification of beta-amyloid (AB) plaques, a key biomarker of the disease
We Are Setting Our Sights on a World Without Alzheimer's
The eye offers a natural window to the brain via the retina. This light-sensitive layer, which lines the interior of the
eye, is an extension of our central nervous system. Recent research has reported the presence of Aβ plaques in the
retinas of both humans and mice who test positive for Alzheimer's Disease.
This discovery opens the possibility that a critical hallmark for Alzheimer's Disease could be detected in the eye by a simple, safe, and non-invasive scan. Learn more here.
7405 Transcanadienne HighwaySuite 330Montréal (Québec)H4T 1Z2